OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review

No abstract is available for this paper.

• Publication year

  2010

• Venue

  World Journal of Pediatrics

• Publication date

  2010-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12519-010-0001-xPMID 20143206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration

  2011cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.

  2008cited by this paper
• Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others

  2007cited by this paper
• Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review

  2007cited by this paper
• Immunostimulants in the prevention of respiratory infections

  2007cited by this paper
• [Immunoregulants improves the prognosis of infants with wheezing].

  2007cited by this paper
• Immunostimulants for preventing respiratory tract infection in children.

  2006cited by this paper
• A review of statistical outlier methods

  2006cited by this paper
• Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review

  2006cited by this paper
• Bias from industry trial funding? A framework, a suggested approach, and a negative result

  2006cited by this paper
• [Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico].

  2005cited by this paper
• Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85

  2005cited by this paper
• Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels

  2003cited by this paper
• Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels.

  2003cited by this paper
• Viral lower respiratory tract infection in infants and young children

  2003cited by this paper
• Clinical Investigations: CoughImmunostimulation with OM-85 in Children with Recurrent Infections of the Upper Respiratory Tract: A Double-Blind, Placebo-Controlled Multicenter Study

  2002influential reference
• Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study

  2001cited by this paper
• Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses.

  2001cited by this paper
• A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells.

  2001cited by this paper
• Serum Antibody Response to Polysaccharides in Children with Recurrent Respiratory Tract Infections

  2001cited by this paper
• Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months.

  2001cited by this paper
• Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.

  2000cited by this paper
• Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemia.

  1999cited by this paper
• Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children.

  1999cited by this paper
• Use of OM-85 BV in primary prevention of acute respiratory tract infections in children in orphanages

  1998cited by this paper
• [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].

  1998cited by this paper
• Efficacy of a Bacterial Extract (OM-85 BV) in Preventing Recurrent Respiratory Tract Infections in Susceptible Children

  1997cited by this paper
• Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

  1997cited by this paper
• [Not Available].

  1997cited by this paper
• Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• OM-85 BV: primary versus secondary prevention.

  1994cited by this paper
• [Vaccine therapy in the treatment of nasal and sinus bacterial allergies].

  1994cited by this paper
• Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group.

  1993cited by this paper
• Influence of OM-85 BV on different humoral and cellular immune defense mechanisms of the respiratory tract.

  1992cited by this paper
• Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections.

  1991influential reference
• [Recurrent respiratory infection in children: its clinical and laboratory evaluation].

  1991cited by this paper
• Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables.

  1990cited by this paper
• Risk factors for recurrent acute otitis media and respiratory infection in infancy.

  1990cited by this paper
• [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].

  1989cited by this paper
• Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial.

  1988cited by this paper
• [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children].

  1986cited by this paper
• [Efficacy of the immunostimulant Broncho-Vaxom].

  1984cited by this paper
• Clinical and immunobiological effects of an orally administered bacterial extract.

  1984cited by this paper
• Clinical study concerning the prevention of infections of the upper respiratory tract of preschool children

  1982cited by this paper
• [Clinical study concerning the prevention of infections of the upper respiratory tract of preschool children].

  1982cited by this paper
• An Introduction to Medical Statistics

  1932cited by this paper

• The bacterial lysate OM-85 Reduces Exacerbations and Oral Corticosteroid Use in Frequently Exacerbating Patients with T2-High Asthma: The OMREXA Real-World Evidence Study.

  2026cites this paper
• Possibilities and prospects of using immunomodulatory therapy in the treatment of acute respiratory infections in children

  2025cites this paper
• Modern Clinical Guidelines for the Management of Patients with Acute Tonsillitis and Pharyngitis

  2025cites this paper
• Adenoiditis in children: A modern view of the etiology and preventive treatment. A review

  2024cites this paper
• OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model.

  2024cites this paper
• Role of OM-85 BV in the prevention of recurrent acute tonsillitis: a retrospective study and literature review

  2024cites this paper
• A critical analysis of the effect of OM‐85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta‐analysis

  2024cites this paper
• Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer

  2024cites this paper
• Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old

  2024cites this paper
• MODERN ASPECTS OF THE TREATMENT OF DIFFERENT ETIOPATHOGENETIC VARIANTS OF CHRONIC NASOPHARYNGITIS

  2024cites this paper
• Persistent cough in children: a pediatric surgeon’s perspective

  2024cites this paper
• Modern Approaches to the Management of Children with Acute Respiratory Viral Infection

  2023cites this paper
• [Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial].

  2023cites this paper
• Prevention of recurrent respiratory tract infections: a literature review of the activity of the bacterial lysate Lantigen B.

  2023cites this paper
• Outcome of Primary Posterior Tracheopexy in Thoracoscopically Repaired Esophageal Atresia Neonates with Tracheomalacia; Single Center's Experience

  2023cites this paper
• A quantitative systems pharmacology workflow towards optimal design and biomarker stratification of atopic dermatitis clinical trials

  2023cites this paper
• Bacterial immunotherapy is highly effective in reducing recurrent upper respiratory tract infections in children: a prospective observational study

  2023cites this paper
• Association of low physical activity with higher respiratory tract infections frequency among pre-school children

  2023cites this paper
• Protection against severe infant lower respiratory tract infections by immune training: Mechanistic studies.

  2022cites this paper
• Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies

  2022cites this paper
• Risk Factors Affecting Development and Persistence of Preschool Wheezing: Consensus Document of the Emilia-Romagna Asthma (ERA) Study Group

  2022cites this paper
• The return of the mixed respiratory bacterial vaccine.

  2022cites this paper
• Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study

  2022cites this paper
• Investigational approaches for unmet need in severe asthma

  2022cites this paper
• Serum Impedance in Children with Recurrent Respiratory Infections.

  2022cites this paper
• The Role of the Microbiome in Asthma Inception and Phenotype

  2022cites this paper
• Efficacy and safety of OM‐85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID‐19 pandemic: A meta‐analysis

  2021cites this paper
• The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions

  2021cites this paper
• Immunomodulating Agents for Pediatric Ear, Nose, and Throat Infections

  2021cites this paper
• Supportive Agents for Pediatric Otolaryngological Infections

  2021cites this paper
• Recent advances in the concept of paraprobiotics: Nutraceutical/functional properties for promoting children health

  2021cites this paper
• Interferoncontaining drugs: clinical, pharmacological, and immunological points of their use for respiratory diseases treatment

  2021cites this paper
• Prevention of recurrent respiratory infections

  2021cites this paper
• Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM‐85

  2021cites this paper
• OM-85 in the prevention of respiratory infections: State-of-the-art and future perspectives in clinical practice.

  2021cites this paper
• Whether Immunostimulants Are Effective in Susceptible Children Suffering From Recurrent Respiratory Tract Infections: A Modeling Analysis Based on Literature Aggregate Data

  2021cites this paper
• Bacterial lysate treatment in allergic disease: A systematic review and meta‐analysis

  2021cites this paper
• Polyvalent Bacterial Lysate Protects Against Pneumonia Independently of Neutrophils, IL-17A or Caspase-1 Activation

  2021cites this paper
• Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM-85

  2021cites this paper
• Streptococcus pneumoniae PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner

  2020cites this paper
• Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid)

  2020cites this paper
• Acupoint Herbal Patching for Long-Term Immune Function in Children with Recurrent Respiratory-Tract Infections: A Systematic Review of Real-World Data

  2020cites this paper
• Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation

  2020influential citation
• Childhood asthma heterogeneity at the era of precision medicine: Modulating the immune response or the microbiota for the management of asthma attack

  2020cites this paper
• Clinical and immunological efficacy of bacterial lysate OM-85 in children with respiratory tract infection

  2020cites this paper
• Paediatric Recurrent Ear, Nose and Throat Infections and Complications: Can We Do More?

  2020cites this paper
• OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study

  2020influential citation
• Immunologic Strategies for Prevention of Asthma.

  2020cites this paper
• Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study

  2019cites this paper
• Microbiota and asthma: Clinical implications.

  2019cites this paper
• The Association of Physical Activity and Sedentary Behaviors with Upper Respiratory Tract Infections and Sleep Duration in Preschool Children—Study Protocol

  2019cites this paper
• Emerging Therapies in the Treatment of Early Childhood Wheeze

  2019cites this paper
• A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections

  2019cites this paper
• The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)

  2019cites this paper
• Immunostimulants in respiratory diseases: focus on Pidotimod

  2019cites this paper
• Почему острые респираторные инфекции у детей остаются актуальной проблемой? Особенности течения, возможности профилактики и лечения

  2019cites this paper
• Immunomodulation Therapy – Clinical Relevance of Bacterial Lysates OM-85

  2019influential citation
• Why do acute respiratory infections in children remain a pressing problem? Current, prevention and treatment options

  2019cites this paper
• Rinossinusites: evidências e experiências

  2019cites this paper
• Health-related quality of life in children and adolescents with congenital diaphragmatic hernia: a cross-sectional study

  2018cites this paper
• Childhood Asthma: Is It All About Bacteria and Not About Viruses? A Pro/Con Debate.

  2018cites this paper
• Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice

  2018cites this paper
• INVITED REVIEW SERIES: PAEDIATRIC AND ADULT BRONCHIECTASIS

  2018cites this paper
• Broncho‐Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta‐analysis

  2018cites this paper
• Frequently ill children: has everything been resolved?

  2018cites this paper
• Primary Prevention of Asthma: Will It Be Possible in the Future?

  2018cites this paper
• Respiratory tract infections in children with Down's Syndrome

  2018cites this paper
• Biomarkers Induced by the Immunomodulatory Bacterial Extract OM-85: Unique Roles for Peyer’s Patches and Intestinal Epithelial Cells

  2017influential citation
• The role of the microbiome in childhood asthma.

  2017cites this paper
• Analysis of molecular genetic study on the polymorphic C-159T locus of the CD14 gene in children with increased risk of recurrent episodes of acute obstructive bronchitis

  2017cites this paper
• The Immunotherapeutic Role of Bacterial Lysates in a Mouse Model of Asthma

  2017cites this paper
• Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP

  2017cites this paper
• OM-85 is an immunomodulator of interferon-β production and inflammasome activity

  2017cites this paper
• Strategies to alter the natural history of childhood asthma

  2017cites this paper
• Острая респираторная вирусная инфекция у детей: современные подходы к диагностике и лечению

  2017cites this paper
• The Calculated Risk of Childhood Asthma From Severe Bronchiolitis.

  2017cites this paper
• Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study

  2017cites this paper
• Intranasal administration of a polyvalent bacterial lysate induces self-restricted inflammation in the lungs and a Th1/Th17 memory signature.

  2016cites this paper
• Protection against maternal infection-associated fetal growth restriction: proof-of-concept with a microbial-derived immunomodulator

  2016cites this paper
• Bacterial extract (OM-85) with human-equivalent doses does not inhibit the development of asthma in a murine model.

  2016cites this paper
• The Gastrointestinal Tract Microbiota and Allergic Diseases

  2016cites this paper
• RESPIRATORY TRACT INFECTIONS IN PAEDIATRIC PATIENTS: PREVENTION OF RECURRENCE AND BEYOND A narrative summary of selected presentations given at the second Encuentro Latinoamericano de Infecciones Respiratorias Recurrentes (ELAIR), an educational summit held in Buenos Aires, Argentina, 4th–5th July 2

  2016cites this paper
• Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections

  2016cites this paper
• Microbes and asthma: Opportunities for intervention.

  2016cites this paper
• Immunomodulation for Recurrent Respiratory Tract Infections: New Insights and Perspectives

  2016cites this paper
• Профилактика бактериальных инфекций дыхательных путей в детском возрасте

  2016cites this paper
• Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma.

  2015cites this paper
• Economic Analysis of the Immunostimulant OM-85 for the Prevention of Paediatric Recurrent Upper Respiratory Tract Infections

  2015cites this paper
• Einfluss der frühkindlichen Zytokinproduktion auf die Entwicklung einer atopischen Dermatitis unter Berücksichtigung einer Intervention mit Pro-Symbioflor®

  2015cites this paper
• Comparative Study of Oral Daily Amoxicillin, Long Acting Intramuscular Penicillin, and Tonsillectomy in Prevention of Recurrent Pharyngitis

  2015cites this paper
• Immunostimulation using bacterial antigens – mechanism of action and clinical practice in viral respiratory tract infections

  2015cites this paper
• Diagnosis and Management of Recurrent Respiratory Tract Infections in Children: A Practical Guide

  2015influential citation
• Bacterial Lysate Increases the Percentage of Natural Killer T Cells in Peripheral Blood and Alleviates Asthma in Children

  2015cites this paper
• Rhinosinusitis: evidence and experience

  2015cites this paper
• Protracted bacterial bronchitis: The last decade and the road ahead

  2015cites this paper
• Immunostymulacja przy użyciu antygenów bakteryjnych – mechanizm działania i praktyka kliniczna w wirusowych zakażeniach układu oddechowego

  2015cites this paper
• Maintenance of Immunological Homeostasis by Indukantha Ghritha in Patients with Recurrent Upper Respiratory Tract Infections—A Pilot Study

  2014cites this paper
• Rhinosinusitis: evidence and experience. A summary

  2014cites this paper
• Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance.

  2014cites this paper
• Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects.

  2014cites this paper